We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+2.29%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$7.22M
Cap. Flow
+$6.17M
Cap. Flow %
5.54%
Top 10 Hldgs %
3.56%
Holding
1,843
New
512
Increased
412
Reduced
454
Closed
458

Top Buys

Rank Stock Value
1
UIS icon
Unisys
UIS
+$562K
2
FLGT icon
Fulgent Genetics
FLGT
+$385K
3
SDGR icon
Schrodinger
SDGR
+$384K
4
AGYS icon
Agilysys
AGYS
+$367K
5
RIOT icon
Riot Platforms
RIOT
+$344K

Top Sells

Rank Stock Value
1
NEXT icon
NextDecade
NEXT
+$565K
2
AMWL icon
American Well
AMWL
+$535K
3
IHRT icon
iHeartMedia
IHRT
+$499K
4
RILY icon
BRC Group Holdings
RILY
+$497K
5
LXRX icon
Lexicon Pharmaceuticals
LXRX
+$496K

Sector Composition

Rank Sector Weight
1 Healthcare 20.49%
2 Industrials 17.12%
3 Technology 16.79%
4 Financials 12.57%
5 Consumer Discretionary 12.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GXO icon
1
GXO Logistics
GXO
$6.07B
$470K 0.42%
8,748
+5,991
+217% +$324K
UIS icon
2
Unisys
UIS
$265M
$454K 0.41%
+92,556
New +$562K
SDGR icon
3
Schrodinger
SDGR
$1.12B
$428K 0.38%
15,853
+13,742
+651% +$384K
LEG icon
4
Leggett & Platt
LEG
$1.46B
$408K 0.37%
21,308
+13,533
+174% +$294K
STRO icon
5
Sutro Biopharma
STRO
$374M
$394K 0.35%
+6,968
New +$308K
AGYS icon
6
Agilysys
AGYS
$3B
$382K 0.34%
+4,537
New +$367K
RIOT icon
7
Riot Platforms
RIOT
$7.53B
$366K 0.33%
29,877
+26,434
+768% +$344K
REVG
8
DELISTED
REV Group
REVG
$362K 0.32%
16,367
+15,618
+2,085% +$292K
TSHA icon
9
Taysha Gene Therapies
TSHA
$1.6B
$353K 0.32%
122,905
-168,711
-58% -$352K
HELE icon
10
Helen of Troy
HELE
$652M
$350K 0.31%
3,037
+2,155
+244% +$257K
CORT icon
11
Corcept Therapeutics
CORT
$9.83B
$347K 0.31%
13,786
+4,802
+53% +$113K
FLGT icon
12
Fulgent Genetics
FLGT
$557M
$339K 0.3%
15,622
+15,519
+15,067% +$385K
ATRC icon
13
AtriCure
ATRC
$1.76B
$339K 0.3%
11,138
+3,986
+56% +$134K
JNJ icon
14
Johnson & Johnson
JNJ
$599B
$339K 0.3%
2,141
+424
+25% +$67.5K
GLDD
15
DELISTED
Great Lakes Dredge & Dock
GLDD
$335K 0.3%
+38,261
New +$315K
POWL icon
16
Powell Industries
POWL
$8.32B
$332K 0.3%
7,005
-594
-8% -$25.4K
ACLS icon
17
Axcelis
ACLS
$4.05B
$330K 0.3%
2,963
+1,050
+55% +$125K
PBYI icon
18
Puma Biotechnology
PBYI
$422M
$329K 0.29%
+61,991
New +$334K
MBI icon
19
MBIA
MBI
$325M
$324K 0.29%
+47,986
New +$304K
XNCR icon
20
Xencor
XNCR
$1.39B
$317K 0.28%
14,306
-1,113
-7% -$24K
TBBK icon
21
The Bancorp
TBBK
$2.8B
$315K 0.28%
9,415
+5,581
+146% +$222K
AAPL icon
22
Apple
AAPL
$4.8T
$312K 0.28%
1,822
+1,470
+418% +$267K
AEIS icon
23
Advanced Energy
AEIS
$11.2B
$312K 0.28%
+3,058
New +$312K
HMN icon
24
Horace Mann Educators
HMN
$2.08B
$307K 0.28%
8,310
+7,582
+1,041% +$269K
ZD icon
25
Ziff Davis
ZD
$2B
$307K 0.28%
4,875
+2,444
+101% +$162K
1
2 3 4 5

Similar funds

SFA
Seneca Financial Advisors Rochester, New York $341M AUM 14.73% 1-Year Est. Return
FCM
Findell Capital Management New York $341M AUM 135.6% 1-Year Est. Return
CPI
Crestview Partners II New York $341M AUM 17.29% 1-Year Est. Return
SW
SMART Wealth Omaha, Nebraska $341M AUM 24.37% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return
GAM
Grandview Asset Management Harrisburg, Pennsylvania $342M AUM 33.52% 1-Year Est. Return
KFSC
Keystone Financial Services (Colorado) Loveland, Colorado $341M AUM 18.11% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

EntryPoint Capital's Q1 2024 Portfolio in Review

As of Q1 2024, EntryPoint Capital held 1,843 positions worth $112M, up 6.9% from $104M the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

EntryPoint Capital deployed $6.17M of net new capital in Q1 2024, opening 512 new positions and adding to 412 existing holdings. Its largest new stake was Unisys: 92,556 shares worth $454K.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was NextDecade, an estimated $565K trimmed.

  • EntryPoint Capital's largest Q1 2024 buy was Unisys: 92,556 shares worth $454K.
  • EntryPoint Capital added most to Fulgent Genetics in Q1 2024, an estimated $385K increase.
  • EntryPoint Capital's biggest Q1 2024 reduction was NextDecade, cutting an estimated $565K.
  • EntryPoint Capital fully exited American Well in Q1 2024, selling an estimated $535K.
  • EntryPoint Capital's ten largest holdings make up 3.6% of its $112M portfolio in Q1 2024.
  • EntryPoint Capital opened 512 new positions and closed 458 in Q1 2024.
  • EntryPoint Capital's portfolio value rose 6.9% quarter-over-quarter to $112M.

Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.